Latigo Biotherapeutics, Inc.

US$12.60As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LTGOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$835.4M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$12
(3.89%)
(65.91%)
Hold 7|1|4|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.33
0.34
0.37
0.38
26.80%
27.80%
27.83%
25.61%
Revenue$M
42.41
43.18
42.61
45.14
9.27%
12.12%
4.72%
8.57%
Peers (US$835.4M)
Cap (US$)
PE
822.8M
197.9x
Capital
TTM
5Y
10Y
Leveragex
0.355
0.123
0.112
EBIT/Intx
0.120
0.257
0.293
Own earn%
(99.46)
(273.90)
(248.42)
Sh yield%
53.87
28.25
28.51
Owners
Insiders/Inst%
11.87
54.76
Short interest%
1.25
SBC / revenue%
4.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
11–17
$1 testx
—
Incr. ROIC%
15